Novo CEO pressed by Senate to cut charges of being overweight, diabetes drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would take into consideration new talks with insurers in regards to the checklist charges of Wegovy and copyright should they pledge to keep the medicines on their formularies. Before https://ricardonevmb.shotblogs.com/rumored-buzz-on-healthcare-news-44650334